XML 20 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statement of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
REVENUES:      
Sales Revenue, Services, Net $ 611,954 $ 780,872 $ 765,428
Sales Revenue, Goods, Net 185,566 304,350 308,080
Total Revenue 797,520 1,085,222 1,073,508
OPERATING EXPENSES:      
Cost of services, exclusive of depreciation shown below 387,739 449,488 444,963
Cost of product sales, exclusive of depreciation shown below 144,913 215,783 218,005
General and administrative expenses, exclusive of depreciation shown below 49,729 45,655 51,988
Depreciation 26,545 25,297 24,168
Amortization 912 1,399 1,303
Other (income) expense, net 3,669 1,069 (338)
Severance and other charges 22,943 0 0
Income Before Interest Expense and Taxes 161,070 346,531 333,419
Interest expense 12,380 10,600 9,317
Income before income tax expense 148,690 335,931 324,102
Income Tax Expense (Benefit) 33,758 77,305 80,908
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 114,932 258,626 243,194
Net Income (Loss) Attributable to Noncontrolling Interest 85 1,141 383
Net income attributable to Core Laboratories N.V. $ 114,847 $ 257,485 $ 242,811
EARNINGS PER SHARE INFORMATION:      
Earnings Per Share, Basic $ 2.69 $ 5.80 $ 5.31
Earnings Per Share, Diluted 2.68 5.77 5.28
Cash dividends per share $ 2.20 $ 2.00 $ 1.28
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:      
Weighted Average Number of Shares Outstanding, Basic 42,747 44,362 45,692
Weighted Average Number of Shares Outstanding, Diluted 42,908 44,600 45,994